Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer
This trial is active, not recruiting.
|Sponsor||Ottawa Hospital Research Institute|
|Start date||June 2012|
|End date||August 2017|
|Trial size||37 participants|
|Trial identifier||NCT01799980, 2009471-01H|
This study will compare two different methods of staging lung cancer to determine whether endobronchial ultrasound (EBUS) staging of mediastinal lymph nodes will provide good diagnostic yield in detecting lung cancer, when compared to current methods of a staging bronchoscopy and cervical mediastinoscopy.
Lung cancer staging
time frame: Pre-op and post-op
Male or female participants at least 18 years old.
Inclusion Criteria: Patients, > 18 years of age, Gender- Males and Female Diagnosis of Non Small Cell Lung Cancer. Patients who have consented on an Ottawa Hospital consent form to undergo a mediastinoscopy procedure or EBUS-TBNA, and a Positron emission tomography (PET) of the chest for lung cancer staging. Exclusion Criteria: Females who are pregnant (or found to be pregnant) during the course of this research study. Patients who do not provide their Ottawa Hospital consent to undergo a staging bronchoscopy , cervical mediastinoscopy or EBUS-TBNA.
|Official title||Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer|
|Principal investigator||Donna E Maziak, MD, MSc|
Call for more information